ORLANDO, FL — When a 65-year-old frail long-term care resident was sent to the ED for the third time in 3 months for lower gastrointestinal bleeding, geriatrics fellow Scott Hanson, DO, was impelled to investigate.
ORLANDO, FL — In a health care world where hospital stays and readmission can cost both acute and PALTC facilities dearly, PALTC practitioners may have the recipe for safe, high-quality, cost-effective care.
ORLANDO, FL — Leadership, passion, and vision are not uncommon qualities possessed by PALTC practitioners. Each year, AMDA – The Society for Post-Acute and Long-Term Care Medicine honors the best of the best with three awards: Medical Director of...
The Food and Drug Administration has approved pimavanserin for the indication of hallucinations and delusions associated with psychosis in Parkinson’s disease.
Patients with rosacea, particularly those older than 60, have an increased risk of being diagnosed with dementia and Alzheimer’s disease, according to Alexander Egeberg, MD, PhD, and his associates. Their findings are published in the Annals of...
Antibiotic use may drive Clostridium difficile transmission within long-term care facilities, according to the results of a recent study published in Annals of Internal Medicine.
Screening asymptomatic patients admitted through the ED for occult Clostridium difficile infection, then isolating those found to be carriers throughout their hospital stay, substantially reduced the incidence of hospital-acquired C. difficile...
AMSTERDAM — Clostridium difficile infections are a major driver of death and nursing home placement in Americans older than 65, according to research presented at a major international conference on infectious diseases.
VANCOUVER — An extended-release amantadine formulation reduced levodopa-induced dyskinesia in a phase III Parkinson’s disease trial from the drug’s developer, Adamas Pharmaceuticals.
